Dr Aaron Holley explores APRV vs low tidal volume ventilation in ARDS, weighing physiologic promise against the need for ...

SAN ANTONIO, October 07, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, ...

All inborn infants, term and preterm ≥29 wk gestation, who were expected to require no respiratory support at birth, were eligible for this study. The study was approved by the Royal Women's Hospital ...

Dr Aaron Holley explores APRV vs low tidal volume ventilation in ARDS, weighing physiologic promise against the need for definitive clinical evidence. Insights from AANEM 2025, including anticipated ...

aState Key Laboratory of Complex Severe and Rare Diseases, Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical ...

Abstract: Controlling and treating respiratory diseases requires monitoring of the respiratory system. Conventional monitoring systems lack portability, which makes continuous monitoring difficult.

Background: CT-guided percutaneous transthoracic needle biopsy (PTNB) is still the main way for obtaining pathological diagnoses of pulmonary nodules. However, the small size and respiratory-induced ...